PRESIDENT HAS SERVED AS A REVIEWER FOR THE BST-F (80) BIOENGINEERING ‘ACADEMIC RESEARCH ENHANCEMENT AWARD’ STUDY SECTION FOR THE NIH

PDX Pharma’s President has served as a reviewer for the BST-F (80) Bioengineering ‘Academic Research Enhancement Award’ Study Section for the National Institute of Health (NIH) held on September 14, 2017.

pdx news

  • COO of PDX Pharma presented at the MedInvest Biotech & Pharma Investor Conference in NYC

    4/15/2024
    read more

  • CEO of PDX Pharma inducted into the National Academy of Inventors for 2024

    3/25/2024
    read more

  • COO of PDX Pharma served as a reviewer on the NIH Scientific Review Panel

    3/14/2024
    read more

Copyright © 2017 PDX Pharmaceuticals, Inc. All rights reserved